BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9633024)

  • 21. Associations between pituitary-adrenocortical function and abdominal obesity, hyperinsulinaemia and dyslipidaemia in normotensive males.
    Hautanen A; Räikkönen K; Adlercreutz H
    J Intern Med; 1997 Jun; 241(6):451-61. PubMed ID: 10497620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.
    Tsigos C; Kyrou I; Chala E; Tsapogas P; Stavridis JC; Raptis SA; Katsilambros N
    Metabolism; 1999 Oct; 48(10):1332-5. PubMed ID: 10535400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of leptin, soluble leptin receptor, resistin, and insulin secretory dynamics in the pathogenesis of hypothalamic obesity in children.
    Guran T; Turan S; Bereket A; Akcay T; Unluguzel G; Bas F; Gunoz H; Saka N; Bundak R; Darendeliler F; Isguven P; Yildiz M; Adal E; Sarikaya S; Baygin LA; Memioglu N; Onal H; Ercan O; Haklar G
    Eur J Pediatr; 2009 Sep; 168(9):1043-8. PubMed ID: 19043735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlled study of the effect of angiotensin converting enzyme inhibition versus calcium-entry blockade on insulin sensitivity in overweight hypertensive patients: Trandolapril Italian Study (TRIS).
    Galletti F; Strazzullo P; Capaldo B; Carretta R; Fabris F; Ferrara LA; Glorioso N; Semplicini A; Mancini M
    J Hypertens; 1999 Mar; 17(3):439-45. PubMed ID: 10100083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients.
    Ueshiba H; Miyachi Y
    Intern Med; 2004 Jul; 43(7):561-5. PubMed ID: 15335180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactate generation following glucose ingestion: relation to obesity, carbohydrate tolerance and insulin sensitivity.
    Lovejoy J; Mellen B; Digirolamo M
    Int J Obes; 1990 Oct; 14(10):843-55. PubMed ID: 2269580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nitrendipine on glucose tolerance and serum insulin and dehydroepiandrosterone sulfate levels in insulin-resistant obese and hypertensive men.
    Beer NA; Jakubowicz DJ; Beer RM; Arocha IR; Nestler JE
    J Clin Endocrinol Metab; 1993 Jan; 76(1):178-83. PubMed ID: 8421087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nifedipine, captopril and prazosin on secretory function of pancreatic beta-cells in hypertensive patients with type-2 (non-insulin-dependent) diabetes and in hypertensive non-diabetics.
    Jasik M; Kasperska-Dworak A; Czyzyk A
    Diabetes Res Clin Pract; 1996 Jun; 33(1):59-66. PubMed ID: 8877277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
    Cabezas-Cerrato J; Garcia-Estevez DA; Araújo D; Iglesias M
    Metabolism; 1997 Feb; 46(2):173-8. PubMed ID: 9030825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity.
    Fernández-Real JM; Ricart W; Casamitjana R
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):583-8. PubMed ID: 9425398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender differences in cardiovascular risk factors in obese, nondiabetic first degree relatives of African Americans with type 2 diabetes mellitus.
    Gaillard TR; Schuster DP; Osei K
    Ethn Dis; 1998; 8(3):319-30. PubMed ID: 9926902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.
    Giordano M; Matsuda M; Sanders L; Canessa ML; DeFronzo RA
    Diabetes; 1995 Jun; 44(6):665-71. PubMed ID: 7789631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
    Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
    Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity.
    Wu MK; Huang CY; Liou YJ; Wang CK; Lee SD
    Int J Obes (Lond); 2008 Mar; 32(3):436-42. PubMed ID: 17955031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGF-1 levels in different conditions of low somatotrope secretion in adulthood: obesity in comparison with GH deficiency.
    Maccario M; Grottoli S; Aimaretti G; Gianotti L; Endrio Oleandri S; Procopio M; Savio P; Tassone F; Ramunni J; Camanni F; Ghigo E
    Minerva Endocrinol; 1999 Jun; 24(2):57-61. PubMed ID: 10941424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparate effects of insulin reduction with diltiazem on serum dehydroepiandrosterone sulfate levels in obese hypertensive men and women.
    Beer NA; Jakubowicz DJ; Beer RM; Nestler JE
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1077-81. PubMed ID: 7962276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.